Article
Primary versus acquired epidermal growth factor receptor Thr790Met mutant non-small cell lung cancer: clinical features and prognoses.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico - 1 Jun 2024
Zhou Siqi, Cai Guoxin, Meng Xue, Li Mengying, Fu Ying, Wang Xiaohan, Wang Kaiyue, Han Xiao
Abstract excerpt
PURPOSE: This study aimed to identify the impact of epidermal growth factor receptor (EGFR) T790M mutations on clinical characteristics and prognosis. METHODS: Retrospective analyses were conducted on the differences on clinicopathological features and prognosis between primary and acquired T790M mutations. Subgroup analyses were performed for primary T790M coexisting with other mutations. RESULTS: Patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
